CD56 Expression in Granulosa Cell Tumors
Author Information
Author(s): Völker Hans-Ullrich, Engert Sabine, Cramer Andreas, Schmidt Melanie, Kämmerer Ulrike, Müller-Hermelink Hans-Konrad, Gattenlöhner Stefan
Primary Institution: University of Würzburg, Institute of Pathology, Würzburg, Germany
Hypothesis
The expression of CD56 isoforms in granulosa cell tumors may indicate their malignant potential.
Conclusion
CD56 expression is a useful diagnostic tool for histopathologists, but it cannot reliably predict the clinical behavior of granulosa cell tumors.
Supporting Evidence
- All tumors expressed CD56Pan, but primary tumors had a higher percentage of positive cells compared to relapses.
- The study found a significant difference in the proliferation rates between primary and relapsed tumors.
- CD56140/180 kDa isoform showed a higher staining intensity in relapsed tumors.
Takeaway
This study looked at a type of ovarian tumor and found that a specific protein, CD56, can help doctors identify these tumors, but it doesn't help them predict how aggressive the tumor will be.
Methodology
The study investigated 30 granulosa cell tumors using immunohistochemical staining to assess CD56 expression.
Potential Biases
The study may have selection bias due to the limited number of cases and the specific patient population.
Limitations
The sample size was small, limiting the ability to make comprehensive statistical evaluations.
Participant Demographics
19 patients with a mix of premenopausal and postmenopausal women.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website